These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6685929)

  • 1. Comparison of plasminogen activator activity in human arteries and veins.
    Ljungnér H; Bergqvist D
    Thromb Res; 1983 Sep; 31(6):779-86. PubMed ID: 6685929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the plasminogen activator activity of superficial hand and foot veins.
    Ljungnér H; Bergqvist D
    Thromb Res; 1982 Dec; 28(5):617-23. PubMed ID: 6891971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some fibrinolytic properties of the human arteries and veins walls.
    Donner L; Vodáková L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):451-9. PubMed ID: 2431965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased fibrinolytic activity in vessels and ureters of rejecting human kidneys.
    Ljungnér H; Bergqvist D; Husberg B; Bergentz SE
    Scand J Urol Nephrol; 1983; 17(3):361-4. PubMed ID: 6359388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.
    Larsson A; Astedt B
    J Clin Pathol; 1985 Feb; 38(2):140-5. PubMed ID: 3881480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relations between activation and inhibition of fibrinolysis in the walls of human arteries and veins.
    Hegt VN
    Thromb Haemost; 1977 Aug; 38(2):407-19. PubMed ID: 579485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasminogen activator of the arterial wall.
    Donner L; Klener P; Roth Z
    Thromb Haemost; 1977 Jun; 37(3):436-43. PubMed ID: 578023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased fibrinolytic activity in human atherosclerotic vessels.
    Ljungnér H; Bergqvist D
    Atherosclerosis; 1984 Jan; 50(1):113-6. PubMed ID: 6538086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of vascular plasminogen activator (v-PA) after venous stasis: electrophoretic-zymographic analysis of free and complexed v-PA.
    Stalder M; Hauert J; Kruithof EK; Bachmann F
    Br J Haematol; 1985 Sep; 61(1):169-76. PubMed ID: 4052324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and variation of fibrinolytic activity in the walls of human arteries and veins.
    Hegt VN
    Haemostasis; 1976; 5(6):355-72. PubMed ID: 1017727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of plasminogen activator in human plasma using the method of fibrin/celite column chromatography--with special reference to the determination of fibrin adsorbable tissue-plasminogen activator by ELISA].
    Ieko M
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):834-47. PubMed ID: 4085966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.
    Hashimoto Y; Kobayashi A; Yamazaki N; Sugawara Y; Takada Y; Takada A
    Thromb Res; 1987 Jun; 46(5):625-33. PubMed ID: 3114907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
    Valen G; Eriksson E; Risberg B; Vaage J
    Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic activity in renal venous blood in man.
    Schrader J; Neuhaus KL; Tebbe U; Köstering H; Scheler F
    Klin Wochenschr; 1986 Jul; 64(13):587-9. PubMed ID: 3747416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant lys-plasminogen given before, but not after, recombinant tissue-type plasminogen activator markedly improves coronary thrombolysis in dogs: relationship of thrombolytic efficacy with parameters of fibrinolysis.
    Chen LY; Nichols WW; Saldeen TG; Mehta JL
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):283-9. PubMed ID: 8720429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura.
    Glas-Greenwalt P; Hall JM; Panke TW; Kant KS; Allen CM; Pollak VE
    J Lab Clin Med; 1986 Nov; 108(5):415-22. PubMed ID: 2430036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen-activator of the arterial wall in occluded arteries.
    Donner L; Klener P; Vodákowá I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):141-7. PubMed ID: 6157618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Releasing of plasminogen-activator from the kidney to the blood (author's transl)].
    Nakata A; Hagita M; Okamoto U
    Nihon Seirigaku Zasshi; 1978 Nov; 40(11):419-26. PubMed ID: 155161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.